These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 32381574)

  • 1. International recommendations on the diagnosis and treatment of acquired hemophilia A.
    Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P
    Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.
    Huth-Kühne A; Baudo F; Collins P; Ingerslev J; Kessler CM; Lévesque H; Castellano ME; Shima M; St-Louis J
    Haematologica; 2009 Apr; 94(4):566-75. PubMed ID: 19336751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should emicizumab be used in patients with acquired hemophilia A?
    Tiede A; Kemkes-Matthes B; Knöbl P
    J Thromb Haemost; 2021 Mar; 19(3):637-644. PubMed ID: 33306259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
    Sakurai Y; Takeda T
    J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.
    Ellsworth P; Chen SL; Kasthuri RS; Key NS; Mooberry MJ; Ma AD
    Blood Adv; 2020 Dec; 4(24):6240-6249. PubMed ID: 33351122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies.
    Marino R
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired haemophilia (acquired factor VIII inhibitor)].
    Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
    Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
    Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R
    Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acquired haemophilia A.
    Tiede A; Scharf RE; Dobbelstein C; Werwitzke S
    Hamostaseologie; 2015; 35(4):311-8. PubMed ID: 25564260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
    Shetty S; Bhave M; Ghosh K
    Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding.
    Pasca S; Zanon E; Mannucci PM; Peyvandi F
    Blood Transfus; 2023 Nov; 21(6):549-556. PubMed ID: 36795341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.